Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Concetta Fargnoli

Showing results (101-110 of 284) with videos related to

Pageof 29
Sort By:
Dermatology and Therapy|October 8, 2025
Dermatologic Comorbidities Associated with Atopic Dermatitis Towards a Shared Therapeutical Approach: A Narrative ReviewMaria Esposito, Alessandro Giunta, Andrea De Berardinis, et al.
The Journal of Dermatological Treatment|April 14, 2025
Reshaping treatment paradigm in actinic keratosis by using a modified Delphi questionnaireThomas Dirschka, Marco Ardigò, Maria Concetta Fargnoli, et al.
Archives of Dermatological Research|February 7, 2023
The role of insomnia in the vulnerability to depressive and anxiety symptoms in atopic dermatitis adult patientsFederico Salfi, Giulia Amicucci, Michele Ferrara, et al.
Molecular Diagnosis & Therapy|January 29, 2017
HLA-C*06:02 Does Not Predispose to Clinical Response Following Long-Term Adalimumab Treatment in Psoriatic Patients: A Retrospective Cohort StudyMarina Talamonti, Marco Galluzzo, Arianna Zangrilli, et al.
Journal of the American Academy of Dermatology|October 8, 2013
Frequency of melanocytic nevi in psoriatic patients is related to treatment and not to disease severityAntonella Di Cesare, Assunta Riitano, Mariano Suppa, et al.
Dermatology Reports|August 18, 2025
Efficacy and safety of risankizumab in patients with erythrodermic and sub-erythrodermic psoriasis: a case seriesAndrea D'Arino, Maria Concetta Fargnoli, Pasquale Frascione, et al.
Expert Opinion on Biological Therapy|May 2, 2025
What is '<i>chronic</i>' pustular psoriasis? Identifying candidates for long-term subcutaneous spesolimab treatmentAngelo Valerio Marzano, Carlo Alberto Maronese, Anna Balato, et al.
Therapeutic Advances in Medical Oncology|January 17, 2022
Identifying candidates for immunotherapy with cemiplimab to treat advanced cutaneous squamous cell carcinoma: an expert opinionGiuseppe Argenziano, Maria Concetta Fargnoli, Fabrizio Fantini, et al.
Expert Opinion on Biological Therapy|March 4, 2025
Psoriasis and cancer: the role of inflammation, immunosuppression, and cancer treatmentManfredo Bruni, Fabio Lobefaro, Cristina Pellegrini, et al.
European Journal of Dermatology : EJD|April 6, 2018
A new dermoscopic algorithm for the differential diagnosis of facial lentigo maligna and pigmented actinic keratosisTamara Micantonio, Luca Neri, Caterina Longo, et al.
Pageof 29

Showing results (101-110 of 284) with videos related to

Sort By:
Pageof 29
Dermatology and Therapy|October 8, 2025
Dermatologic Comorbidities Associated with Atopic Dermatitis Towards a Shared Therapeutical Approach: A Narrative ReviewMaria Esposito, Alessandro Giunta, Andrea De Berardinis, et al.
The Journal of Dermatological Treatment|April 14, 2025
Reshaping treatment paradigm in actinic keratosis by using a modified Delphi questionnaireThomas Dirschka, Marco Ardigò, Maria Concetta Fargnoli, et al.
Archives of Dermatological Research|February 7, 2023
The role of insomnia in the vulnerability to depressive and anxiety symptoms in atopic dermatitis adult patientsFederico Salfi, Giulia Amicucci, Michele Ferrara, et al.
Molecular Diagnosis & Therapy|January 29, 2017
HLA-C*06:02 Does Not Predispose to Clinical Response Following Long-Term Adalimumab Treatment in Psoriatic Patients: A Retrospective Cohort StudyMarina Talamonti, Marco Galluzzo, Arianna Zangrilli, et al.
Journal of the American Academy of Dermatology|October 8, 2013
Frequency of melanocytic nevi in psoriatic patients is related to treatment and not to disease severityAntonella Di Cesare, Assunta Riitano, Mariano Suppa, et al.
Dermatology Reports|August 18, 2025
Efficacy and safety of risankizumab in patients with erythrodermic and sub-erythrodermic psoriasis: a case seriesAndrea D'Arino, Maria Concetta Fargnoli, Pasquale Frascione, et al.
Expert Opinion on Biological Therapy|May 2, 2025
What is '<i>chronic</i>' pustular psoriasis? Identifying candidates for long-term subcutaneous spesolimab treatmentAngelo Valerio Marzano, Carlo Alberto Maronese, Anna Balato, et al.
Therapeutic Advances in Medical Oncology|January 17, 2022
Identifying candidates for immunotherapy with cemiplimab to treat advanced cutaneous squamous cell carcinoma: an expert opinionGiuseppe Argenziano, Maria Concetta Fargnoli, Fabrizio Fantini, et al.
Expert Opinion on Biological Therapy|March 4, 2025
Psoriasis and cancer: the role of inflammation, immunosuppression, and cancer treatmentManfredo Bruni, Fabio Lobefaro, Cristina Pellegrini, et al.
European Journal of Dermatology : EJD|April 6, 2018
A new dermoscopic algorithm for the differential diagnosis of facial lentigo maligna and pigmented actinic keratosisTamara Micantonio, Luca Neri, Caterina Longo, et al.
Pageof 29